V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010020 | 310005645 | 1.67 | 87.6 | Palliative (P) | 2014-07-13 | 2014-07-13 | CETUXIMAB + RT | 2 | N | 310024447 | METHOTREXATE |
| 310010021 | 310005647 | 1.55 | 54.1 | Palliative (P) | 2018-02-12 | 2018-02-21 | Topotecan (intravenous) | N | null | 310024565 | TRASTUZUMAB |
| 310010022 | 310011348 | 1.81 | null | Palliative (P) | 2016-03-02 | 2016-04-23 | GC Int Guide Excranial GermCell JEB | N | N | 310024614 | CETUXIMAB |
| 310010023 | 310005649 | null | 66.3 | Curative (C) | 2018-11-15 | 2018-11-15 | RCEOP | N | N | 310024693 | CYTARABINE INTRATHECAL |
| 310010024 | 310005651 | 1.58 | 56.6 | Palliative (P) | 2014-11-15 | 2015-02-09 | IVADo | 2 | null | 310024822 | TRABECTEDIN |
| 310010025 | 310005652 | null | 82.3 | Curative (C) | 2018-01-27 | 2018-01-27 | CYCLOPHOSPHAMIDE + VINBLASTINE | 2 | N | 310024857 | DHAP - R |
| 310010026 | 310005655 | 1.88 | 66.7 | Adjuvant (A) | 2018-08-04 | 2018-08-04 | Gemcitabine + Oxaliplatin | 2 | N | 310024978 | ALEMTUZUMAB |
| 310010027 | 310005656 | 1.73 | null | Palliative (P) | null | 2018-12-15 | Triple Intrathecal | N | N | 310025026 | VEMURAFENIB |
| 310010028 | 310008519 | 1.74 | 54 | Palliative (P) | 2013-06-26 | 2014-09-23 | Bevacizumab+Carbo+Gemcitabine | 02 | N | 310025101 | DABRAFENIB |
| 310010029 | 310010043 | 1.73 | 48 | Palliative (P) | 2018-05-03 | 2018-11-18 | PEG INTERFERON | 2 | N | 310025220 | CAV |
| 310010030 | 310010043 | 1.74 | 83 | Palliative (P) | 2018-12-14 | 2019-01-07 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 310025220 | TEMOZOLOMIDE |
| 310010031 | 310010043 | 1.65 | 74.4 | Adjuvant (A) | 2017-03-15 | 2017-03-20 | Doxorubin 50mg/m2 | N | N | 310025220 | PEG INTERFERON |
| 310010032 | 310008521 | 1.77 | 90.8 | Curative (C) | 2018-06-21 | 2018-07-05 | BCG Intravesical | N | N | 310025400 | ICE-R |
| 310010033 | 310005667 | 1.68 | 57.6 | Curative (C) | 2016-03-08 | 2018-01-09 | IPILIMUMAB + NIVOLUMAB | 2 | N | 310025467 | CAPECITABINE |
| 310010034 | 310005673 | null | 92.399 | null | 2018-12-04 | 2018-12-12 | Cetuximab +Cisplatin + FU (Cycle 1) | N | null | 310025486 | IFOSFAMIDE |
| 310010035 | 310008528 | 1.7 | 78.7 | null | 2016-03-20 | 2017-07-30 | Vinblastine | 2 | N | 310025663 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310010036 | 310005679 | 1.6 | 55.8 | Palliative (P) | 2015-03-17 | 2015-04-09 | STS Rhabdo RMS 2005 Vin Cyclo | N | null | 310025707 | OCTOPUS TRIAL |
| 310010037 | 310008530 | 1.58 | 90 | Palliative (P) | 2014-11-11 | 2014-11-11 | ABVD | 02 | N | 310025747 | EPOC TRIAL |
| 310010038 | 310011350 | 0 | 70.75 | Palliative (P) | 2016-12-29 | 2016-12-29 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 310001814 | CISPLATIN + ETOPOSIDE |
| 310010039 | 310005683 | 1.86 | 83.3 | Curative (C) | 2018-01-22 | 2018-02-14 | CARBOPLATIN + RT | null | N | 310001900 | BENDAMUSTINE |
| 310010040 | 310005684 | null | 54.5 | Curative (C) | 2019-01-10 | 2019-01-10 | IMATINIB | 02 | N | 310002058 | IVE-R |
| 310010041 | 310005687 | null | 0 | Palliative (P) | 2020-04-25 | 2020-04-28 | INTERFERON | N | N | 310002637 | METHOTREXATE |
| 310010042 | 310008534 | 1.83 | 67 | Palliative (P) | 2018-08-31 | 2018-09-16 | Cetuximab 7 day (Cycle 1) | N | N | 310003186 | CISPLATIN + ETOPOSIDE |
| 310010043 | 310008535 | 1.5 | 54.1 | Palliative (P) | 2016-08-12 | 2016-08-16 | Trastuzumab Subcutaneous | null | null | 310003715 | METHOTREXATE |
| 310010044 | 310005701 | 1.68 | 50.45 | Palliative (P) | 2019-03-01 | 2019-03-13 | Oxaliplatin + Modified de Gramont | 02 | N | 310010646 | LENALIDOMIDE |
| 310010045 | 310005702 | 1.62 | 76.3 | Palliative (P) | 2019-02-27 | 2019-03-04 | Vinblastine | 02 | N | 310010899 | TRASTUZUMAB |
| 310010046 | 310005704 | null | 58.7 | Curative (C) | 2017-04-16 | 2017-04-18 | PEG INTERFERON | null | N | 310011301 | SUNITINIB |
| 310010047 | 310005706 | 1.5 | 62.5 | Palliative (P) | 2018-12-11 | 2018-12-14 | Bendamustine + prednisolone | 2 | N | 310012020 | ICE |
| 310010048 | 310005707 | 1.54 | null | Curative (C) | 2016-01-09 | 2016-01-22 | TOPOTECAN | 2 | N | 310013605 | TRABECTEDIN |
| 310010049 | 310005707 | null | 62.1 | Curative (C) | 2017-03-14 | 2017-03-16 | RCEOP | N | N | 310013605 | BORTEZOMIB |
| 310010050 | 310008543 | 1.8 | 86.7 | Curative (C) | 2015-12-26 | 2016-06-25 | INTERFERON | 2 | null | 310016083 | TRASTUZUMAB |
| 310010051 | 310005712 | 1.57 | 44.8 | Palliative (P) | 2019-02-22 | 2019-05-23 | R GCVP | null | null | 310018375 | CISPLATIN + FLUOROURACIL |
| 310010052 | 310005715 | 1.69 | 0 | Palliative (P) | 2018-06-06 | 2018-06-06 | ICE | N | N | 310020717 | ICE-R |
| 310010053 | 310005718 | null | 61.6 | Palliative (P) | 2018-04-27 | 2018-08-16 | Trabectedin | N | null | 310021650 | DOXORUBICIN |
| 310010054 | 310005719 | 1.52 | 67 | Disease modification (D) | 2017-08-09 | 2017-09-01 | Methotrexate High Dose (3g/m2) | N | N | 310022131 | METHOTREXATE HIGH DOSE |
| 310010055 | 310005719 | 1.75 | 79.4 | Palliative (P) | 2016-08-05 | 2016-08-28 | Gemcitabine + Oxaliplatin | N | N | 310022131 | CTD |
| 310010056 | 310005724 | null | 83 | Palliative (P) | 2019-02-18 | 2019-02-27 | Capecitabine (21 day) + Irinotecan | N | N | 310024427 | CARBOPLATIN + PEMETREXED |
| 310010057 | 310005728 | 1.61 | 75 | Palliative (P) | 2019-02-27 | 2019-11-07 | TOPOTECAN | 2 | N | 310004470 | INTERFERON |
| 310010058 | 310005729 | 1.75 | null | Palliative (P) | 2016-01-23 | 2016-06-10 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 310005025 | DOXORUBICIN + OLARATUMAB |
| 310010059 | 310008551 | 1.49 | 54 | Disease modification (D) | 2019-03-15 | 2019-03-16 | DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 2 | N | 310019348 | CISPLATIN + ETOPOSIDE |
| 310010060 | 310010883 | 1.76 | null | Curative (C) | 2015-12-17 | 2015-12-19 | Trabectedin | N | N | 310020717 | METHOTREXATE HIGH DOSE |
| 310010061 | 310011764 | 1.67 | 85.3 | Disease modification (D) | 2018-01-22 | 2018-02-08 | VAC | N | null | 310024445 | RCEOP |
| 310010062 | 310005732 | 1.67 | 82 | null | 2019-12-23 | 2019-12-27 | Temozolomide 150mg/m2 | null | N | 310002808 | CYCLOPHOSPHAMIDE + DOXORUBICIN |
| 310010063 | 310010063 | 1.7 | 61.25 | Adjuvant (A) | 2018-09-28 | 2018-11-03 | ICON8B TRIAL | N | N | 310002808 | TOPOTECAN |
| 310010064 | 310005734 | 1.53 | 59.7 | Palliative (P) | 2018-11-21 | 2018-11-22 | TOPOTECAN | 02 | N | 310023725 | TRABECTEDIN |
| 310010065 | 310008555 | 1.75 | 0 | Palliative (P) | 2017-08-29 | 2017-09-27 | Sunitinib | N | null | 310003166 | CYCLO + ETOPOSIDE + NELARABINE |
| 310010066 | 310002694 | 1.68 | 67.1 | Palliative (P) | 2017-08-25 | 2017-08-31 | Carboplatin AUC 6 - 10 | 2 | N | 310000365 | CARBOPLATIN |
| 310010067 | 310002703 | 1.7 | 53 | Palliative (P) | null | 2013-11-23 | Paclitaxel 7 day | N | N | 310003947 | PACLITAXEL |
| 310010068 | 310002705 | 1.75 | 74 | Palliative (P) | 2017-08-16 | 2017-08-18 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 310003952 | CARBOPLATIN + PACLITAXEL |
| 310010069 | 310002712 | 1.64 | 99.8 | Neo-adjuvant (N) | 2017-05-17 | 2017-05-18 | Carboplatin + Paclitaxel (3 weekly) | N | N | 310003972 | CARBOPLATIN + PACLITAXEL |